Princess Nourah Bint Abdulrahman University Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2018
NCT04654624
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Ishrat Rahman | Princess Noura Bint Abdulrhman University | Princess Nourah Bint Abdulrahman University

Active Ingredients

Drugs in Phase 3 Trials (2)

ibuprofen (motrin) (1 trial)

silver diammine fluoride (1 trial)

Drugs in Phase 2 Trials (4)

artemisinin (1 trial)

artesunate (1 trial)

caraway seed (1 trial)

chlorhexidine (hibitane) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 2)

Dental Caries (Phase 3)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 6